Free Science & Technology Newsletter!

Get these great stories sent directly to your email!

email See more free newsletters on the subscribe page.

Type your email address:

Your email address is safe with us. View our Privacy policy.

Vocabulary Hangman:
Try our FREE ArcaMax Vocabulary Hangman Game
The Funnies:
Get free jokes, comics, and more! See them all on
our funnies page

Malaysian medicine cuts chemo resistance

MONTREAL (UPI) -- A Canadian, U.S. and Austrian study has discovered a Malaysian folk medication reduces resistance to cancer chemotherapy treatments.

McGill University researchers said the study focused on a class of natural products known as cyclopenta benzofuran flavaglines, or CBFs. Working with mice genetically modified to mimic human leukemias, they found the CBF compound silvestrol can make tumors susceptible to the killing effects of anticancer drugs.

Silvestrol is a natural compound derived from a large genus of trees and shrubs found in Malaysia, South China and some Pacific islands, the scientists said. It's been used in Malaysian folk medicine for generations, but never as a cancer therapy.

The researchers cautioned trials in humans and possible treatments are still many years away.

The results of the study that included Boston University, the Sloan-Kettering Cancer Center, the University of Vienna and the Howard Hughes Medical Institute are published in the June issue of The Journal of Clinical Investigation.



Copyright 2008 by United Press International

This news arrived on: 07/01/2008
Share this Story
Digg   del.icio.us   Yahoo   Reddit   Facebook   Google

Printer Friendly Version | Send this page to a friend | Post Comment


Rate This Story:

Great - 5 - 4 - 3 - 2 - 1 - Bad




Posted Comments:


Comment archive | Comment FAQ's

Post Comment::

Author:
Subject:



Recent archives Featured news

View Science & Technology ezine stories by date or visit the complete archive

Featured Channel: Politics

The ArcaMax Politics channel is one of 70 content categories offered by ArcaMax Publishing on this ...